Bridging the Transition to Life After Cancer Treatment
为癌症治疗后的生活过渡架起桥梁
基本信息
- 批准号:8060993
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-14 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAftercareAmericanAreaAttentionCancer BurdenCancer CenterCancer PatientCancer SurvivorCancer SurvivorshipCaringCenters for Disease Control and Prevention (U.S.)ChronicClinicClinical OncologyCommunicationCommunitiesComprehensive Cancer CenterContinuity of Patient CareCrowdingDiagnosisDietitianDisabled PersonsEarly DiagnosisEarly treatmentEconomicsEquilibriumFamily PracticeFrequenciesHealthHealth PersonnelHealth ProfessionalHealthcareHealthcare SystemsIndividualInstitute of Medicine (U.S.)InstitutionJournalsLate EffectsLearningLengthLifeMalignant NeoplasmsMedicalMedically Underserved AreaMethodsMinnesotaMinorMinorityMinority GroupsMissionModelingMonitorNational Cancer InstituteNursesOncologic NursingOncologistOncology NurseOutcomePatientsPhasePhysiciansPopulationPreventivePrimary Care PhysicianPrimary Health CareProcessProviderQuality of lifeRecommendationReportingResearchResourcesRoleServicesSocial WorkersSurveysSymptomsSystemTestingTimeTranslationsTreatment ProtocolsUncertaintyUniversitiesUniversity of Minnesota Cancer CenterVolunteer GroupWomanWorkactive methodaging populationbasecancer diagnosiscancer recurrencecancer therapydiscountend of life careexperiencefallsfunctional outcomeshealth care qualityhealth care service organizationhealth disparityimprovedinterestmedical specialtiesmeetingsmemberminority healthmultidisciplinaryneoplasm resourceoncologyprofession allied to medicineprogramspsychologicpsychosocialsurvivorshipsymposiumwaiver
项目摘要
DESCRIPTION (provided by applicant): Building on the 2006 Institute of Medicine (IOM) report, "From Cancer Patient to Cancer Survivor: Lost in Translation", the Minnesota Cancer Alliance (www.mncanceralliance.org) and the Masonic Cancer Center at the University of Minnesota (www.cancer.umn.edu) are proposing an educational conference for health care professionals on helping their cancer patients successfully navigate the transition from cancer treatment to life after treatment. The National Cancer Institute's Office of Cancer Survivorship Research states that "an individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life". It has been estimated that as of January 2006, 11.4 million Americans (3.8% of the population) met the definition of a cancer survivor, and with advances in early detection and treatment cancers, the number of cancer survivors is expected to grow. The projected shortage of oncologists in the coming years combined with an aging population has led many in the cancer survivorship community to consider alternatives to oncologist-led care for the growing numbers of cancer survivors, including "shared-care" where a patient is managed by two or more medical specialties, nurse-led models of survivorship care, and specialized survivorship clinics providing multidisciplinary care in one setting. In addition, other health care professionals, including nurses, physical therapists, social workers, and dietitians, are beginning to define their role in the cancer survivorship care team. With the proposed 2-day conference, we plan to bring oncologists, primary care and family practice physicians, nurses and allied health professionals together to learn about the needs of patients transitioning from active cancer treatment to life beyond cancer, and the resources available to meet those needs. We are also especially interested in encouraging women, racial and ethnic minorities, people with disabilities, and teams of health care professionals from medically underserved areas and populations to attend the conference. We anticipate being able to offer a number of registration waivers for minority health care providers, those who provide health care to minorities, or those who practice in Health Professional Shortage Areas. Priority and registration discounts will be offered for multidisciplinary groups of 4 or more professionals (preferably including at least one MD and one RN) from the same institution or community to encourage the formation and implementation of a team approach to providing survivorship care services following the conference. Methods for improving communication between health care professionals will be discussed in educational and networking sessions, and a team approach will be encouraged in order to meet the individual needs of cancer survivors in a realistic, time- and resource-effective manner.
PUBLIC HEALTH RELEVANCE: This educational conference for health care professionals will directly address the mission of NCI's Office of Cancer Survivorship by helping to enhance the quality and length of survival of people with cancer. The proposed conference also addresses one of the recommendations in the Center for Disease Control's National Action Plan for Cancer Survivorship to "educate health care providers about cancer survivorship from diagnosis through long-term treatment and end-of life care".
描述(由申请人提供):根据 2006 年医学研究所 (IOM) 报告“从癌症患者到癌症幸存者:迷失在转化中”,明尼苏达癌症联盟 (www.mncanceralliance.org) 和明尼苏达大学共济会癌症中心 (www.cancer.umn.edu) 提议为医疗保健专业人员举办一次教育会议,以帮助他们的癌症患者成功完成癌症治疗的过渡 治疗后恢复正常生活。美国国家癌症研究所癌症生存研究办公室指出,“一个人从诊断之时起,直至其一生都被视为癌症幸存者”。据估计,截至 2006 年 1 月,有 1140 万美国人(占人口的 3.8%)符合癌症幸存者的定义,并且随着癌症早期检测和治疗的进步,癌症幸存者的数量预计还会增加。预计未来几年肿瘤科医生的短缺加上人口老龄化,导致癌症幸存者社区中的许多人考虑为越来越多的癌症幸存者提供由肿瘤科医生主导的护理的替代方案,包括由两个或多个医学专业管理患者的“共享护理”、护士主导的生存护理模式以及在一个环境中提供多学科护理的专业生存诊所。此外,其他医疗保健专业人员,包括护士、物理治疗师、社会工作者和营养师,也开始确定他们在癌症生存护理团队中的角色。通过拟议的为期 2 天的会议,我们计划将肿瘤学家、初级保健和家庭医生、护士和专职医疗专业人员聚集在一起,了解患者从积极的癌症治疗过渡到超越癌症的生活的需求,以及满足这些需求的可用资源。我们还特别有兴趣鼓励妇女、少数族裔、残疾人以及来自医疗服务不足地区和人群的医疗保健专业人员团队参加会议。我们预计能够为少数族裔医疗保健提供者、为少数族裔提供医疗保健的人员或在卫生专业人员短缺地区执业的人员提供多项注册豁免。来自同一机构或社区的由 4 名或以上专业人员(最好包括至少一名医学博士和一名注册护士)组成的多学科团体将获得优先权和注册折扣,以鼓励在会议后形成和实施提供幸存者护理服务的团队方法。将在教育和网络会议中讨论改善医疗保健专业人员之间沟通的方法,并将鼓励采用团队方法,以便以现实、节省时间和资源的方式满足癌症幸存者的个人需求。
公共健康相关性:这次针对医疗保健专业人员的教育会议将通过帮助提高癌症患者的生存质量和延长生存时间来直接解决 NCI 癌症生存办公室的使命。拟议的会议还讨论了疾病控制中心的国家癌症生存行动计划中的建议之一,即“对医疗保健提供者进行关于癌症生存从诊断到长期治疗和临终关怀的教育”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kimberly Z Robien其他文献
Kimberly Z Robien的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kimberly Z Robien', 18)}}的其他基金
Body composition and chemotherapy toxicity among women being treated for breast cancer
接受乳腺癌治疗的女性的身体成分和化疗毒性
- 批准号:
10406912 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Body composition and chemotherapy toxicity among women being treated for breast cancer
接受乳腺癌治疗的女性的身体成分和化疗毒性
- 批准号:
10197290 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
Genetic Variation in Vitamin D Metabolism and BMT Outcomes
维生素 D 代谢和 BMT 结果的遗传变异
- 批准号:
7693828 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Genetic Variation in Vitamin D Metabolism and BMT Outcomes
维生素 D 代谢和 BMT 结果的遗传变异
- 批准号:
7509511 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Epidemiology of Cancer in a Cohort of Older Women
老年女性群体的癌症流行病学
- 批准号:
8066666 - 财政年份:1985
- 资助金额:
$ 0.5万 - 项目类别:
Epidemiology of Cancer in a Cohort of Older Women
老年女性群体的癌症流行病学
- 批准号:
7887847 - 财政年份:1985
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别: